APP2APP Virtual Lectures, Inc

APP2APP Virtual Lectures, Inc is a national Advanced Practice Provider corporation which was formed to allow more experienced Physician Assistants (PAs) and Nurse Practitioners (NPs) to share their knowledge with APP colleagues via delivery of high quality FREE up-to-date Virtual Lectures and reasonably priced one-to-one or small group Educational & Training Packages focused on day-to-day clinical practice. 

The mission of APP2APP Virtual Lectures, Inc. is to provide quality education and resources to enhance the knowledge and clinical skills of PAs and NPs to ultimately improve the quality of patient care within the communities nationwide. 

Visit our YouTube channel or our website to learn more. 


 

Obesity: A Disease of Abnormal Physiology - GLP1-RA, the New Molecule on the Block!

596 views
June 17, 2024

Lecturer: Martine Altieri, PA-C

https://app2app.org/

Join Martine Altieri, PA-C from Boca Raton, Florida who practices in cardiology. She recently started an obesity clinic within her medical practice. Martine has been a PA for twelve years and has experience in cardiology, primary care and hospital medicine.

Obesity has long been recognized as an epidemic in the US. The physiology of weight loss undeniably involves a complex interplay between genetics, environment, behavior and neuroendocrine physiology. Many experts today, like Martine, recognize obesity as a disease, though this theory is not accepted by all. The lack of clear and specific diagnostic criteria, robust double-blinded randomized studies, and the concern that classifying obesity as a disease may make patients less willing to implement lifestyle behavioral changes and rely solely on medications for life-long management.

Martine will discuss the physiology of adipose tissue inflammation and dysfunction, identify adiposity-related diseases, help you understand the peripheral and central signals controlling energy intake, discuss the role of gut hormones, particularly role of GLP1, and she will share with you why she advocates the use of GLP-agonists in her practice.

Comments 0
Login to view comments. Click here to Login